跳至主要内容
临床试验/DRKS00024581
DRKS00024581尚未招募未知

Evaluation of glaucoma or ocular hypertension patients with pre-existing ocular surface disease switched from a preserved prostaglandin analog – timolol fixed combination to a preservative – free latanoprost – timolol fixed combination

Department of Ophthalmology, University hospital center Zagreb0 个研究点目标入组 30 人开始时间: 2021年3月29日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Adult (?18years) patients
  • With open angle galucoma or ocular hypertension that had been controlled (stable IOP <19mmHg) by commercially available preserved PGA –timolol FC for at least 3 months
  • Stable visual field (based on at least two reliable visual field tests performed within the last 12 months)
  • Central corneal thickness within the range 500-580µm.
  • mild to moderate hyperaemia based on MacMonnies (scores 1 and 2)

排除标准

  • Best-corrected visual acuity (BCVA) 0,1 or lower
  • Severe visual field defects (MD 12 dB or higher)
  • Any intraocular surgery (other than filtration surgery performed at least 6 months before screening)
  • Any ocular surface abnormality preventing accurate IOP measurement
  • Acute ocular inflammation
  • Contact lens wearers

研究者

发起方
Department of Ophthalmology, University hospital center Zagreb

相似试验